HealthCare Royalty Partners delivers innovative structured financing solutions for royalty owners and healthcare companies to fund their corporate and development goals. We are focused on investing in commercial stage products and companies through the monetization of passive royalties, creation of Synthetic Royalty® financings and the purchase of structured debt and equity. This investment strategy has proven to create long-term value for both royalty owners and our investors.

Cardiorentis Announces €45 Million Financing

HC Royalty Announces Follow-on Investment in AcuFocus

HC Royalty Acquires Orenitram™ Royalties for $30 Million

HC Royalty is a premier global healthcare investment firm:
   
 
  • Manage over $3 billion in capital
  • Experienced team of healthcare investment professionals
  • World-class investor base